Edgewise Therapeutics, Inc. Number of Operating Segments
Edgewise Therapeutics, Inc. (EWTX) reported Number of Operating Segments of 1 segment for the 9-month period ending 2024-09-30, per its 10-Q filed 2024-11-07.
Financial Statements › Notes › Segment Reporting
us-gaap:NumberOfOperatingSegments · last filed 2024-11-07
- Edgewise Therapeutics, Inc. number of operating segments for the quarter ending 2024-03-31 was 1.00 segment, a 0.00% change year-over-year.
- Edgewise Therapeutics, Inc. number of operating segments for the quarter ending 2023-03-31 was 1.00 segment, a 0.00% change year-over-year.
- Edgewise Therapeutics, Inc. number of operating segments for the quarter ending 2022-03-31 was 1.00 segment, a 0.00% change year-over-year.
- Edgewise Therapeutics, Inc. number of operating segments for the quarter ending 2021-03-31 was 1.00 segment.
- Edgewise Therapeutics, Inc. number of operating segments for fiscal 2023 was 1.00 segment, a 0.00% change from fiscal 2022.
- Edgewise Therapeutics, Inc. number of operating segments for fiscal 2022 was 1.00 segment, a 0.00% change from fiscal 2021.
- Edgewise Therapeutics, Inc. number of operating segments for fiscal 2021 was 1.00 segment.
| Period end | Number of Operating Segments 3 month | Number of Operating Segments 6 month | Number of Operating Segments 9 month | Number of Operating Segments 12 month |
|---|---|---|---|---|
| 2024-09-30 | 1.00 segment 10-Q · filed 2024-11-07 | |||
| 2024-06-30 | 1.00 segment 10-Q · filed 2024-08-08 | |||
| 2024-03-31 | 1.00 segment 10-Q · filed 2024-05-09 | |||
| 2023-12-31 | 1.00 segment 10-K · filed 2024-02-22 | |||
| 2023-09-30 | 1.00 segment 10-Q · filed 2023-11-09 | |||
| 2023-06-30 | 1.00 segment 10-Q · filed 2023-08-10 | |||
| 2023-03-31 | 1.00 segment 10-Q · filed 2023-05-11 | |||
| 2022-12-31 | 1.00 segment 10-K · filed 2023-02-23 | |||
| 2022-09-30 | 1.00 segment 10-Q · filed 2022-11-03 | |||
| 2022-06-30 | 1.00 segment 10-Q · filed 2022-08-04 | |||
| 2022-03-31 | 1.00 segment 10-Q · filed 2022-05-11 | |||
| 2021-12-31 | 1.00 segment 10-K · filed 2022-02-24 | |||
| 2021-09-30 | 1.00 segment 10-Q · filed 2021-11-10 | |||
| 2021-06-30 | 1.00 segment 10-Q · filed 2021-08-09 | |||
| 2021-03-31 | 1.00 segment 10-Q · filed 2021-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Viking Therapeutics, Inc. (VKTX) | United States | $4.287B | -8.51 |
| Indivior Pharmaceuticals, Inc. (INDV) | $4.250B | 14.09 | |
| Tango Therapeutics, Inc. (TNGX) | United States | $4.154B | -42.53 |
| Veradermics, Inc (MANE) | United States | $4.839B | |
| AbCellera Biologics Inc. (ABCL) | $3.879B | -14.59 | |
| Erasca, Inc. (ERAS) | United States | $5.073B | -19.96 |
| Dianthus Therapeutics, Inc. /DE/ (DNTH) | United States | $5.082B | -27.79 |
| ACADIA PHARMACEUTICALS INC (ACAD) | United States | $3.823B | 11.45 |
| PTC THERAPEUTICS, INC. (PTCT) | United States | $5.199B | -177.07 |
| Xenon Pharmaceuticals Inc. (XENE) | $3.684B | -14.27 |